Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Shares Outstanding (Weighted Average) (2020 - 2025)

Trulieve Cannabis (TCNNF) has 5 years of Shares Outstanding (Weighted Average) data on record, last reported at $191.3 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 0.7% year-over-year to $191.3 million; the TTM value through Dec 2025 reached $191.3 million, up 0.7%, while the annual FY2025 figure was $191.3 million, 0.7% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $191.3 million in Q4 2025 per TCNNF's latest filing, roughly flat from $191.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $191.3 million in Q4 2025 and bottomed at $139.4 million in Q4 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $186.4 million, with a median of $189.5 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Weighted Average): skyrocketed 34.89% in 2022, then grew 0.31% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $139.4 million in 2021, then surged by 34.89% to $188.0 million in 2022, then rose by 0.52% to $189.0 million in 2023, then grew by 0.54% to $190.0 million in 2024, then rose by 0.7% to $191.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $191.3 million in Q4 2025, $191.3 million in Q3 2025, and $191.2 million in Q2 2025.